[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100409584":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":16,"locations":25,"responsibleParty":45,"collaborators":7,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":7,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":7,"enrollmentInfo":57,"targetDuration":7,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":7,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"University Hospital Heidelberg","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Assesment of Effectiveness and side effects","Case Report forms, Quality of life questionaire",[13],{"name":14,"affiliation":5,"role":15},"Laila König, MD","PRINCIPAL_INVESTIGATOR",[17,22],{"name":14,"role":18,"phone":19,"phoneExt":20,"email":21},"CONTACT","+49 6221","2801","laila.könig@med.uni-heidelberg.de",{"name":23,"role":18,"phone":19,"phoneExt":20,"email":24},"Adriane Hommertgen, Phd","adriane.hommertgen@med.uni-heidelberg.de",[26],{"facility":5,"status":27,"city":28,"state":7,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Heidelberg","69120","Germany","DE",{"type":33,"coordinates":34},"Point",[35,36],8.69079,49.40768,{"lat":36,"lon":35},[39,44],{"name":40,"role":18,"phone":41,"phoneExt":42,"email":43},"Juergen Debus, Professor","06221 56","8201","juergen.debus@med.uni-heidelberg.de",{"name":14,"role":15,"phone":7,"phoneExt":7,"email":7},{"type":15,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Juergen Debus","Head of Department","100409584","registry-study-of-proton-radiotherapy-in-lymphoma-100409584",false,"NCT04613388","Registry Study of Proton Radiotherapy in Lymphoma","Multicenter Registry Study on Proton Radiotherapy for Mediastinal Lymphomas","Inclusion Criteria:\n\nHistologically confirmed lymphoma according to WHO\n\n* Patient consent\n* Patient age ≥18 years.\n* Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation).\n* Ability of the patient to give consent\n\nExclusion Criteria:\n\nAge \\\u003C18 years\n\n* Non-consent of the patient to the disclosure of his data\n* Cancellation of the patient's participation in the study","ALL","18 Years",{"count":58,"type":59},200,"ESTIMATED","OBSERVATIONAL","The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.",[63],"Mediastinal Lymphoma","2026-04-28",{"date":66,"type":67},"2026-04-29","ACTUAL",{"date":69,"type":67},"2018-08-01",{"date":71,"type":59},"2031-08-01",{"name":5,"class":6},1]